Japan and U.S. Lead Innovation in Live Attenuated Vaccines
The Live Attenuated Vaccines Market is experiencing rapid expansion, projected to grow from USD 25.3 billion in 2023 to USD 70.4 billion by 2032. The market is driven by increased demand for robust, long-lasting immunizations, innovations in oral and intranasal delivery systems, and rising infectious disease threats worldwide. Growth is especially strong in the United States, Japan, and across Asia-Pacific, as governments increase funding and regulatory support for advanced vaccine development and deployment. To Get Free Sample Report : https://www.datamintelligence.com/download-sample/live-attenuated-vaccines-market Key Growth Drivers Rising Prevalence of Infectious Diseases Global disease outbreaks from measles and polio to newer respiratory viruses are increasing the urgency of effective immunization. Live attenuated vaccines, which mimic natural infections without causing disease, are particularly effective at building durable immunity and reducin...